HUANG Siping (黃思萍)

Patents (CityU)

  1. 2023
  2. Accepted/In press/Filed

    Immortalization of Primary Resting T Cells by CRISPR/dCas9-Based Epigenetic Modifiers and Transcriptional Activators

    HUANG, S., LAM, H. W. R., LAU, C. H. & TIN, C., 22 Feb 2023, (Accepted/In press/Filed) Priority No. 63/486,250

    Research output: Patents, Agreements and Assignments (RGC: 51, 52)51_Patents (CityU)

    Check@CityULib